<p> Objective: to evaluate the structure and volume of expenditures on treatment of patients with different clinical forms of psoriasis using the method of analysis of "cost of illness". Material and Methods. The study was conducted on the basis of the Clinic for Skin and Venereal Diseases Medical University of the Saratov State Medical University n.a. V. I. Razumovsky. To determine the costs of treating patients with different clinical forms of psoriasis, 702 medical records of a stationary patient have been analyzed. To assess and analyze the costs of treating patients with psoriasis, one of the methods of clinical and economic analysis was used-the "cost of illness". In the analysis of costs, the costs of inpatient treatment were in...
Background: Psoriasis is a chronic disease that can have accompanying comorbidities including arthri...
Background: Psoriasis is a chronic inflammatory disease of the skin that has a major effect on an in...
Objective: to perform cost-effectiveness analysis of the treatment for adult patients with psoriatic...
Psoriasis is a chronic immune-mediated inflammatory skin disease accompanied by the gradual involvem...
Treatment modalities of chronic plaque psoriasis have dramatically changed over the past ten years w...
Treatment modalities of chronic plaque psoriasis have dramatically changed over the past ten years w...
The objective of this study was to assess the cost of caring for patients with psoriasis in Italy ac...
Background Although costs of biologics are high, effective treatment of patients with psoriasis may ...
BACKGROUND: Present trends in hospital management are facilitating the utilization of more accurate ...
Psoriasis is a chronic inflammatory, immune-mediated skin disorder that affects 1.5-1.8 million peop...
Estimates of direct and indirect costs of psoriasis are limited. The aim of this study was to estima...
Objectives: Knowledge of the societal costs of psoriasis is limited. This study estimated the cost o...
Psoriasis is a chronic inflammatory, immune-mediated skin disorder that affects 1.5-1.8 million peop...
Treatment modalities of chronic plaque psoriasis have dramatically changed over the past ten years w...
Psoriasis is a chronic inflammatory, immune-mediated skin disorder that affects 1.5-1.8 million peop...
Background: Psoriasis is a chronic disease that can have accompanying comorbidities including arthri...
Background: Psoriasis is a chronic inflammatory disease of the skin that has a major effect on an in...
Objective: to perform cost-effectiveness analysis of the treatment for adult patients with psoriatic...
Psoriasis is a chronic immune-mediated inflammatory skin disease accompanied by the gradual involvem...
Treatment modalities of chronic plaque psoriasis have dramatically changed over the past ten years w...
Treatment modalities of chronic plaque psoriasis have dramatically changed over the past ten years w...
The objective of this study was to assess the cost of caring for patients with psoriasis in Italy ac...
Background Although costs of biologics are high, effective treatment of patients with psoriasis may ...
BACKGROUND: Present trends in hospital management are facilitating the utilization of more accurate ...
Psoriasis is a chronic inflammatory, immune-mediated skin disorder that affects 1.5-1.8 million peop...
Estimates of direct and indirect costs of psoriasis are limited. The aim of this study was to estima...
Objectives: Knowledge of the societal costs of psoriasis is limited. This study estimated the cost o...
Psoriasis is a chronic inflammatory, immune-mediated skin disorder that affects 1.5-1.8 million peop...
Treatment modalities of chronic plaque psoriasis have dramatically changed over the past ten years w...
Psoriasis is a chronic inflammatory, immune-mediated skin disorder that affects 1.5-1.8 million peop...
Background: Psoriasis is a chronic disease that can have accompanying comorbidities including arthri...
Background: Psoriasis is a chronic inflammatory disease of the skin that has a major effect on an in...
Objective: to perform cost-effectiveness analysis of the treatment for adult patients with psoriatic...